Viewing Study NCT03371693


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-04-10 @ 3:07 AM
Study NCT ID: NCT03371693
Status: UNKNOWN
Last Update Posted: 2020-05-29
First Post: 2017-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
Sponsor: Zhongnan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module